Evangelos Kiskinis

9.2k total citations · 5 hit papers
54 papers, 5.1k citations indexed

About

Evangelos Kiskinis is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Evangelos Kiskinis has authored 54 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 17 papers in Neurology and 15 papers in Cellular and Molecular Neuroscience. Recurrent topics in Evangelos Kiskinis's work include Amyotrophic Lateral Sclerosis Research (12 papers), CRISPR and Genetic Engineering (11 papers) and Pluripotent Stem Cells Research (11 papers). Evangelos Kiskinis is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (12 papers), CRISPR and Genetic Engineering (11 papers) and Pluripotent Stem Cells Research (11 papers). Evangelos Kiskinis collaborates with scholars based in United States, United Kingdom and Germany. Evangelos Kiskinis's co-authors include Kevin Eggan, Alexander Meissner, Gabriella L. Boulting, Christoph Bock, Malcolm G. Parker, Gist F. Croft, Mackenzie W. Amoroso, Derek H. Oakley, Andreas Gnirke and Zachary D. Smith and has published in prestigious journals such as Science, Cell and Journal of Biological Chemistry.

In The Last Decade

Evangelos Kiskinis

53 papers receiving 5.0k citations

Hit Papers

Reference Maps of Human E... 2011 2026 2016 2021 2011 2017 2014 2014 2021 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Reference Maps of Human ES and iPS Cell Variation Enable High-Throughput Characterization of Pluripotent Cell Lines
    2011 713 citations Evangelos Kiskinis, Zachary D. Smith et al. profile →
  2. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease
    2017 625 citations Lena F. Burbulla, Pingping Song et al. Science profile →
  3. Axonal Transport of TDP-43 mRNA Granules Is Impaired by ALS-Causing Mutations
    2014 497 citations Luis A. Williams, Evangelos Kiskinis et al. Neuron profile →
  4. Intrinsic Membrane Hyperexcitability of Amyotrophic Lateral Sclerosis Patient-Derived Motor Neurons
    2014 481 citations Evangelos Kiskinis, Luis A. Williams et al. profile →
  5. Bioactive scaffolds with enhanced supramolecular motion promote recovery from spinal cord injury
    2021 276 citations Zaida Álvarez, Alexandra N. Edelbrock et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evangelos Kiskinis United States 28 3.4k 1.2k 887 792 650 54 5.1k
Gabsang Lee United States 29 3.9k 1.2× 864 0.7× 1.2k 1.3× 802 1.0× 373 0.6× 68 5.7k
Oleksandr Platoshyn United States 37 3.4k 1.0× 450 0.4× 1.0k 1.1× 1.0k 1.3× 599 0.9× 68 6.2k
Paul R. Heath United Kingdom 48 3.3k 1.0× 2.5k 2.2× 972 1.1× 1.3k 1.7× 1.4k 2.2× 131 6.7k
Luís Pereira de Almeida Portugal 45 3.9k 1.2× 848 0.7× 2.4k 2.7× 552 0.7× 266 0.4× 148 6.1k
Maeve A. Caldwell United Kingdom 38 2.9k 0.9× 595 0.5× 1.9k 2.2× 447 0.6× 700 1.1× 86 5.1k
Alison C. Lloyd United Kingdom 30 2.7k 0.8× 549 0.5× 2.6k 2.9× 648 0.8× 492 0.8× 52 5.9k
Jasna Križ Canada 40 1.6k 0.5× 1.8k 1.5× 915 1.0× 631 0.8× 842 1.3× 104 5.5k
Yongquan Luo United States 31 3.2k 1.0× 311 0.3× 948 1.1× 726 0.9× 726 1.1× 50 4.8k
Tetsuya Nagata Japan 28 2.3k 0.7× 1.1k 1.0× 716 0.8× 477 0.6× 836 1.3× 107 3.8k
Rosario Sánchez‐Pernaute Spain 33 3.4k 1.0× 1.5k 1.3× 3.0k 3.4× 442 0.6× 588 0.9× 75 5.6k

Countries citing papers authored by Evangelos Kiskinis

Since Specialization
Citations

This map shows the geographic impact of Evangelos Kiskinis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evangelos Kiskinis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evangelos Kiskinis more than expected).

Fields of papers citing papers by Evangelos Kiskinis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evangelos Kiskinis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evangelos Kiskinis. The network helps show where Evangelos Kiskinis may publish in the future.

Co-authorship network of co-authors of Evangelos Kiskinis

This figure shows the co-authorship network connecting the top 25 collaborators of Evangelos Kiskinis. A scholar is included among the top collaborators of Evangelos Kiskinis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evangelos Kiskinis. Evangelos Kiskinis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alessandrini, Francesco, Matthew Wright, Tatsuaki Kurosaki, et al.. (2025). TDP-43 dysfunction compromises UPF1-dependent mRNA metabolism in ALS. Neuron. 114(4). 640–660.e10.
2.
George, Alfred L. & Evangelos Kiskinis. (2024). The Need for Speed; Investigating Channelopathy-Associated Epilepsy Using High Throughput Electrophysiological Approaches. Epiliepsy currents. 24(5). 345–349. 1 indexed citations
3.
Chi, Wanhao & Evangelos Kiskinis. (2024). Integrative analysis of epilepsy-associated genes reveals expression-phenotype correlations. Scientific Reports. 14(1). 3587–3587. 4 indexed citations
4.
Smela, Merrick Pierson, et al.. (2024). SeqVerify: An accessible analysis tool for cell line genomic integrity, contamination, and gene editing outcomes. Stem Cell Reports. 19(10). 1505–1515. 1 indexed citations
5.
Ortega, J. Alberto, Ivan R. Sasselli, Marco Boccitto, et al.. (2023). CLIP-Seq analysis enables the design of protective ribosomal RNA bait oligonucleotides against C9ORF72 ALS/FTD poly-GR pathophysiology. Science Advances. 9(45). eadf7997–eadf7997. 5 indexed citations
6.
Martin, Éric, et al.. (2023). Polyurethane Culture Substrates Enable Long-Term Neuron Monoculture in a Human in vitro Model of Neurotrauma. SHILAP Revista de lepidopterología. 4(1). 682–692. 1 indexed citations
7.
Mann, Jacob R., Francesco Alessandrini, Eric N. Anderson, et al.. (2023). Loss of function of the ALS-associated NEK1 kinase disrupts microtubule homeostasis and nuclear import. Science Advances. 9(33). eadi5548–eadi5548. 18 indexed citations
8.
Gleixner, Amanda M., Eric N. Anderson, Nandini Ramesh, et al.. (2022). NUP62 localizes to ALS/FTLD pathological assemblies and contributes to TDP-43 insolubility. Nature Communications. 13(1). 3380–3380. 35 indexed citations
9.
Simkin, Dina, Bernabé I. Bustos, Christina M. Ambrosi, et al.. (2022). Homozygous might be hemizygous: CRISPR/Cas9 editing in iPSCs results in detrimental on-target defects that escape standard quality controls. Stem Cell Reports. 17(4). 993–1008. 36 indexed citations
10.
Simkin, Dina, Christina M. Ambrosi, Luis A. Williams, et al.. (2022). ‘Channeling’ therapeutic discovery for epileptic encephalopathy through iPSC technologies. Trends in Pharmacological Sciences. 43(5). 392–405. 14 indexed citations
11.
Simkin, Dina, Carlos G. Vanoye, Reshma R. Desai, et al.. (2021). Dyshomeostatic modulation of Ca2+-activated K+ channels in a human neuronal model of KCNQ2 encephalopathy. eLife. 10. 26 indexed citations
12.
Sonobe, Yoshifumi, Gopinath Krishnan, Ghanashyam D. Ghadge, et al.. (2021). A C. elegans model of C9orf72-associated ALS/FTD uncovers a conserved role for eIF2D in RAN translation. Nature Communications. 12(1). 6025–6025. 36 indexed citations
13.
Álvarez, Zaida, Alexandra N. Edelbrock, Ivan R. Sasselli, et al.. (2021). Bioactive scaffolds with enhanced supramolecular motion promote recovery from spinal cord injury. Science. 374(6569). 848–856. 276 indexed citations breakdown →
14.
Charlton, Jocelyn, Alexandra L. Mattei, Jing Liao, et al.. (2020). TETs compete with DNMT3 activity in pluripotent cells at thousands of methylated somatic enhancers. Nature Genetics. 52(8). 819–827. 82 indexed citations
15.
Ramesh, Nandini, Elizabeth L. Daley, Amanda M. Gleixner, et al.. (2020). RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3. Acta Neuropathologica Communications. 8(1). 177–177. 22 indexed citations
16.
Simkin, Dina & Evangelos Kiskinis. (2018). Modeling Pediatric Epilepsy through iPSC-Based Technologies. Epiliepsy currents. 18(4). 240–245. 24 indexed citations
17.
Burbulla, Lena F., Pingping Song, Joseph R. Mazzulli, et al.. (2017). Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease. Science. 357(6357). 1255–1261. 625 indexed citations breakdown →
18.
Burbulla, Lena F., Pingping Song, Joseph R. Mazzulli, et al.. (2017). Dopamine oxidation mediates a human-specific cascade of mitochondrial and lysosomal dysfunction in Parkinson's disease.. 1 indexed citations
19.
Ichida, Justin K. & Evangelos Kiskinis. (2015). Probing disorders of the nervous system using reprogramming approaches. The EMBO Journal. 34(11). 1456–1477. 38 indexed citations
20.
Christian, Mark, et al.. (2005). RIP140-Targeted Repression of Gene Expression in Adipocytes. Molecular and Cellular Biology. 25(21). 9383–9391. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gabsang Lee Breakdown of academic impact, for papers by Oleksandr Platoshyn Breakdown of academic impact, for papers by Paul R. Heath Breakdown of academic impact, for papers by Luís Pereira de Almeida Breakdown of academic impact, for papers by Maeve A. Caldwell Breakdown of academic impact, for papers by Alison C. Lloyd Breakdown of academic impact, for papers by Jasna Križ Breakdown of academic impact, for papers by Yongquan Luo Breakdown of academic impact, for papers by Tetsuya Nagata Breakdown of academic impact, for papers by Rosario Sánchez‐Pernaute
Rankless by CCL
2026